The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
Researchers used data from 7 observational studies to evaluate the impact of glucose status on cognitive performance at 3 to 6 months after stroke among patients with normal fasting glucose, impaired...
In a recent study, researchers investigated whether women with multiple sclerosis have an increased risk of relapse after pregnancy, and whether this risk is impacted by breastfeeding or disease-modifying...
In a recent systematic review, researchers investigated the influence of inheritance patterns and family history rates in cluster headache. Here is what they found.
The American Heart Association/American Stroke Association’s Stroke Council Leadership has released temporary emergency guidance on stroke care during the COVID-19 pandemic.
Investigators of the RESTORE BRAIN study determined whether a selective GABAA α5 receptor antagonist is a safe and effective therapy for patients with ischemic stroke.
After identifying 3 neuroprotective drugs acting on different axonal pathobiologies, the researchers assessed each drug’s efficacy on percentage brain volume change among patients with secondary progressive...
Can apolipoprotein CIII plasma concentration predict whether a patient with coronary artery disease is at greater risk for experiencing ischemic stroke or a transient ischemic attack? Here are the results...